Oruka Therapeutics (ORKA) Net Income Growth (1y) (2011 - 2024)
Oruka Therapeutics (ORKA) Net Income Growth (1y) (2011 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -0.46% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 17,802.13% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 59.59% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -10.08% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 63.48% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Oruka Therapeutics | 949.58 Mn | 118.43 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -1,085.44% |
| Mar 31, 2024 | -408.27% |
| Dec 31, 2023 | 5.03% |
| Sep 30, 2023 | 26.35% |
| Jun 30, 2023 | 58.26% |
| Mar 31, 2023 | 58.24% |
| Dec 31, 2022 | 79.32% |
| Sep 30, 2022 | 49.17% |
| Jun 30, 2022 | 24.41% |
| Mar 31, 2022 | 19.60% |
| Dec 31, 2021 | -8.24% |
| Sep 30, 2021 | -136.66% |
| Jun 30, 2021 | -271.27% |
| Mar 31, 2021 | -211.14% |
| Dec 31, 2020 | -327.73% |
| Sep 30, 2020 | -72.23% |
| Jun 30, 2020 | 9.33% |
| Mar 31, 2020 | 20.67% |
| Dec 31, 2019 | 17.66% |
| Sep 30, 2019 | 27.43% |